Challenging Transfemoral Valve-in-Valve Implantation in a Degenerated Stentless Bioprosthetic Aortic Valve
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) seems to be an effective and promising procedure in patients with degenerated bioprosthetic aortic valves avoiding the risks associated with the use of cardioplegia and redo cardiac surgery.
Outcomes Following Transcatheter Aortic Valve Replacement in the United States
A national registry (the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy [STS/ACC TVT] Registry) was initiated to meet a condition for Medicare coverage and also facilitates outcome assessment and comparison with other trials and international registries. This study reports the initial US commercial experience with TAVR.
Comparison of Transfemoral Transcatheter Aortic Valve Replacement Performed in the Catheterization Laboratory (Minimalist Approach) Versus Hybrid Operating Room (Standard Approach): Outcomes and Cost Analysis
The aim of this study was to compare transfemoral transcatheter aortic valve replacement (TF TAVR) performed in a catheterization laboratory (minimalist approach [MA]) with TF TAVR performed in a hybrid operating room (standard approach [SA]).
Hypothermic Cardiopulmonary Bypass Without Exchange Transfusion in Sickle-Cell Patients: A Matched-Pair Analysis
Sickle-cell patients undergo cardiopulmonary bypass (CPB) surgery in our institution without perioperative exchange transfusion. We sought to determine whether this protocol increased mortality or important sickle-cell-related complications.
Preoperative Anemia Increases Mortality and Postoperative Morbidity after Cardiac Surgery
This study evaluates the effect of preoperative anemia on early clinical outcomes in patients undergoing cardiac surgery.
Is There Evidence that Fresh Frozen Plasma is Superior to Antithrombin Administration to Treat Heparin Resistance in Cardiac Surgery?
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was, 'in [patients with heparinresistance] is [treatment with FFP] superior [to antithrombin administration] in [achieving adequate anticoagulation to facilitate safe cardiopulmonary bypass]?'
New Aspects of Anesthetic Management in Congenital Heart Disease “Common Arterial Trunk”
Management of "common arterial trunk" (CAT) after surgical repair depends on the adequacy of treatment, cardiac function, level of pulmonary arterial hypertension (PAH), and degree of bleeding.
Feasibility and Safety of Biventricular Repair in Neonates with Hypoplastic Left Heart Complex
The objective of this study was to assess the outcome of the biventricular approach in hypoplastic left heart complex (HLHC). We evaluated retrospectively 30 neonates diagnosed with HLHC from the "12 de Octubre" University Hospital, following established criteria.
A Randomized, Double Blind Trial of Prophylactic Fibrinogen to Reduce Bleeding in Cardiac Surgery
Postoperative bleeding has a great clinical importance and can contribute to increased mortality and morbidity in patients undergoing coronary artery bypass graft surgery. In this prospective, randomized, double-blind study, we evaluated the effect of prophylactic administration of fibrinogen concentrate on post-coronary artery bypass graft surgery bleeding.
The Influence of Heparin Resistance on Postoperative Complications in Patients Undergoing Coronary Surgery
Heparin resistance is relatively frequent in patients undergoing coronary surgery. We aimed to assess the impact of heparinresistance on the outcome of patients undergoing coronary surgery with cardiopulmonary bypass (CABG). Three definitions of heparin resistance were adopted.
Outcomes and Prosthesis Choice for Active Aortic Valve Infective Endocarditis: Analysis of The Society of Thoracic Surgeons Adult Cardiac Surgery Database
National prosthesis use in active aortic valve infective endocarditis (IE) is unreported. Prosthesis usage and outcomes in patients undergoing an aortic valve operation with active IE was evaluated.The Society of Thoracic Surgeons Adult Cardiac Surgery Database was used to identify patients with active IE who underwent an aortic valve operation from January 1, 2005, to June 30, 2011.
Incremental Value of Anemia in Cardiac Surgical Risk Prediction With the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II Model
Anemia is a risk factor for adverse events after cardiac operations. We evaluated the incremental value of preoperative anemia over the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II to predict hospital death after cardiac operations.